The Renoprotective Effects of Docosahexaenoic Acid as an Add-on Therapy in Patients Receiving Eicosapentaenoic Acid as Treatment for IgA Nephropathy: A Pilot Uncontrolled Trial

OBJECTIVE: Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) have been reported to have beneficial effects in patients with IgA nephropathy (IgAN). Although DHA and EPA have different mechanisms of action, no study to date has assessed their individual actions in patients with IgAN. This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriyama, Takahito, Kumon, Saeko, Kamiyama, Takahiro, Karasawa, Kazunori, Uchida, Keiko, Nitta, Kosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820033/
https://www.ncbi.nlm.nih.gov/pubmed/29093399
http://dx.doi.org/10.2169/internalmedicine.9155-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820033/
https://www.ncbi.nlm.nih.gov/pubmed/29093399
http://dx.doi.org/10.2169/internalmedicine.9155-17

Ejemplares similares